By Hugo Francisco de Souza A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for ...

Eli Lilly and Company has reported detailed findings from the ACHIEVE-3 Phase III trial comparing the efficacy and safety of ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

The most recent version of NG28, the National Institute for Health and Care Excellence's (NICE) guidelines for managing type 2 diabetes in adults, has been released on February 18, 2026.

Chinese researchers say a patient with Type 2 diabetes is now insulin-free after stem cell treatment. Experts call it promising but caution that more large-scale trials are needed.

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

Managing type 2 diabetes often means finding the right mix of medications, lifestyle changes, and ongoing support. With many type 2 diabetes medications available today, it can feel overwhelming to ...

Read more about why patients with type 2 diabetes will now be offered SGLT-2 inhibitors much earlier in the treatment process.

W hen first diagnosed with type 2 diabetes, you may have been able to manage blood sugar levels with diet, exercise, and a first-line medication. But as the condition progresses, the body becomes more ...

If you have type 2 diabetes, it’s important to manage your hormone levels, as an imbalance can alter how your body responds to insulin. Lifestyle measures like reducing stressors and eating a balanced ...

Millions of people with type 2 diabetes could live longer, healthier lives under new NICE recommendations that put individual needs at the heart of treatment decisions. In final guidance published by ...